Connect your AI

Acadia Healthcare ACHC PP&E Sale Proceeds

PP&E Sale Proceeds at other companies

CoreCivicCXW

$7K-58.8%

Other financials

Income statement

Revenue$828.8M+7.6%

Net income$4.1M-51.0%

EPS (diluted)$0.05-44.4%

Balance sheet

Cash & equivalents$158.5M+73.7%

Total debt$2.7B+14.7%

Total equity$2.0B-35.6%

Total assets$5.5B-9.8%

Cash flow

Operating cash flow$61.5M+436%

CapEx$76.6M-56.2%

Free cash flow-$15.0M+90.8%

Valuation

Market cap$2.26B-23.6%

Enterprise value$4.77B-7.7%

P/S0.7×-0.3×

Profitability

Net margin-32.8%-38.8pp

FCF margin-8.7%-0.1pp

Returns & leverage

Return on equity-44.3%-50.6pp

Debt / equity1.4×+0.6×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by Acadia Healthcare in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.

The official record: Acadia Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Healthcare's pp&e sale proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Acadia Healthcare's PP&E sale proceeds?: Acadia Healthcare (ACHC) reported PP&E sale proceeds of $16.38M in Q1 2026.
How has Acadia Healthcare's PP&E sale proceeds changed year-over-year?: Acadia Healthcare's PP&E sale proceeds increased by 38000.0% year-over-year, from $43K to $16.38M.
What is the long-term trend for Acadia Healthcare's PP&E sale proceeds?: Over 4 years (2021 to 2025), Acadia Healthcare's PP&E sale proceeds has grown at a 61.6% compound annual growth rate (CAGR), from $3.49M to $23.85M.
What does PP&E sale proceeds mean?: Cash received from selling property, plant, and equipment no longer needed for operations.